The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iron Mountain Inc
NYSE:IRM
|
US |
|
P
|
Procter & Gamble Co
DUS:PRG
|
US |
|
I
|
Iovance Biotherapeutics Inc
SWB:2LB
|
US |
|
Solstad Maritime ASA
OTC:SLTMF
|
NO |
|
Secom Co Ltd
F:XSC
|
JP |
|
Unico Silver Ltd
OTC:USLRF
|
AU |
|
Gersan Elektrik Ticaret ve Sanayi AS
OTC:GERLF
|
TR |
|
S
|
Societe Generale SA
SWB:SGE1
|
FR |
|
Vcplus Ltd
SGX:43E
|
MY |
|
Grupo Aeroportuario del Centro Norte SAB De CV
BMV:OMAB
|
MX |
|
Colonial SFL SOCIMI SA
MAD:COL
|
ES |
|
Aegon NV
AEX:AGN
|
NL |
|
Public Storage
NYSE:PSA
|
US |
|
Novanta Inc
F:1GSN
|
US |
|
Garrett Motion Inc
NASDAQ:GTX
|
CH |
|
P
|
Powszechna Kasa Oszczednosci Bank Polski SA
XMUN:P9O
|
PL |
|
E
|
EnSync Inc
OTC:ESNC
|
US |
|
AML3D Ltd
ASX:AL3
|
AU |
|
A
|
Axon Enterprise Inc
F:TCS
|
US |
|
A
|
Arkema SA
F:V1S
|
FR |
|
M
|
MC Mining Ltd
XMUN:G1V
|
AU |
|
A
|
Absa Group Ltd
JSE:ABG
|
ZA |
|
Burckhardt Compression Holding AG
F:B5H
|
CH |
|
Diploma PLC
OTC:DPMAY
|
UK |
Iron Mountain Inc (IRM)’s 12-month stock price forecast through October 2027 has a consensus target of $146.88, implying 27% upside. The forecast is based on price targets from 13 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
IRM is 146.88 USD with a low forecast of 133.32 USD and a high forecast of 162.75 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 8%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 4 years is 6%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 14%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 77%.
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 80%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more